Physician profile
Keith G Goodfellow
NPI 1164573515
$846.73
in general payments reported to CMS, 2019-2025
18 companies · $54.84 in 2025
The $54.84 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.94 · 2020: $90.54 · 2021: $275 · 2022: $77.35 · 2023: $251 · 2024: $54.68 · 2025: $54.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $360.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $320.24 | 2020-2023 | |
| Coopersurgical, INC. | $90.34 | 2023-2025 | Summit Doppler, Paragard T 380a |
| Hologic Sales and Service, LLC | $54.20 | 2020-2024 | Aptima |
| Merck Sharp & Dohme LLC | $43.23 | 2019-2021 | |
| Lsi Solutions INC | $38.44 | 2021 | |
| Organon LLC | $36.76 | 2022-2025 | Jada System, Nexplanon |
| Baxter Healthcare | $34.90 | 2020 | |
| Pfizer INC. | $31.70 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $29.63 | 2023 | Myfembree |
| Mayne Pharma Commercial LLC | $28.47 | 2023 | |
| Avion Pharmaceuticals | $26.89 | 2020-2021 | |
| Mallinckrodt Enterprises LLC | $17.50 | 2019 | |
| Novo Nordisk INC | $16.72 | 2024 | Ozempic, Rybelsus |
| Myovant Sciences INC. | $16.35 | 2021 | |
| Astellas Pharma US INC | $16.26 | 2023 | Myrbetriq |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $16.00 | 2021 | |
| Mylan Pharmaceuticals INC. | $14.69 | 2021 | |
| Amag Pharmaceuticals, INC. | $14.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Goodfellow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.